In CRC cell-derived EVs, miR-25 targets and inhibits the expression of SIRT6, while SIRT6 inhibits the expression of Lin28b/NRP-1, leading to suppressed viability, migration, and invasion of CRC cells. Here, NRP1 is linked to colorectal carcinoma.